Register now for the 30th Alzheimer Europe Online Conference

#30AEC Early Bird rate ends soon - book now!

 

There are just 2 weeks left to take advantage of our special Early Bird rate for the 30th Alzheimer Europe Conference #30AEC.

 

Conference registration gives you admission to all sessions, access to poster presentations, to chat rooms and to all conference videos after the event.

 

To ensure our event is as engaging and interactive as possible, you will also have:

  • the unique opportunity to interact with over 280 already confirmed speakers giving 158 oral presentations, 60 quick oral presentations and 94 poster presentations
  • the chance to meet other conference delegates in discussion forums, and to interact with the sponsors and exhibitors
  • the ability to arrange online meetings with speakers, delegates, sponsors and exhibitors.

 

The early bird rate of EUR 75 (instead of EUR 125) is only available until 15 September 2020. Don’t miss out, book today!

 

 

Special rates are available for people with dementia, students, members of Alzheimer Europe. Click here for more information.

 

The programme for our virtual conference can be found on our website. Click here.

 

 

Neuronet call for abstracts

 

General abstract submissions for the 30th Alzheimer Europe Conference are now closed, and we would like to thank all the participants and presenters. 

 

Abstract submission to the Neuronet Early-Career Researcher Sessions will remain open until 15 September. Please note that these sessions are restricted to Early-Career Researchers (defined as graduate students or those within 10 years of finishing their graduate studies) who wish to present their work on the following IMI neurodegeneration projects:

 

ADAPTED, Aetionomy, AMYPAD, EMIF, EPAD, EQIPD, IDEA-FAST, IMPRiND, IM2PACT, Mobilise-D, MOPEAD, PD-MIND, PDMitoQUANT, PHAGO, PRISM, RADAR-AD, RADAR-CNS and ROADMAP

 

Click here to see more details and submit an abstract.

 

 



Follow the event on Twitter #30AEC

 

The 30th AE Conference received funding under an operating grant from the European Union’s Health Programme (2014-2020). Alzheimer Europe gratefully acknowledges the support of all conference sponsors.
European Commission